Abstract: The invention discloses a series of compounds that are based on imidazole scaffold bearing trigonelline unit. The compound may include one or more substituents on the imidazole ring. The compound is a hybrid molecule. Further, a one-pot synthesis method of preparing the hybrid molecule is disclosed. The reaction is conducted in primary alcohol medium with benzil or a substituted benzil, nicotinaldehyde, ammonium acetate, and a primary amine as reactants. The reaction uses iodine, zirconyl chloride or ferric chloride as catalyst at a temperature of 40 – 80 °C. The reactants may also include one or more substituents. When 2-aminoheptane was used as a substituent it was observed to have high anticancer activity in the chosen three liver cancer cell lines with the maximum potent cytotoxic effect. (FIG. 1A)
Claims:To be attached , Description:To be attached
| # | Name | Date |
|---|---|---|
| 1 | 202141006956-STATEMENT OF UNDERTAKING (FORM 3) [19-02-2021(online)].pdf | 2021-02-19 |
| 2 | 202141006956-FORM 1 [19-02-2021(online)].pdf | 2021-02-19 |
| 3 | 202141006956-DRAWINGS [19-02-2021(online)].pdf | 2021-02-19 |
| 4 | 202141006956-DECLARATION OF INVENTORSHIP (FORM 5) [19-02-2021(online)].pdf | 2021-02-19 |
| 5 | 202141006956-COMPLETE SPECIFICATION [19-02-2021(online)].pdf | 2021-02-19 |
| 6 | 202141006956-Proof of Right [03-04-2021(online)].pdf | 2021-04-03 |
| 7 | 202141006956-Correspondence, Form-1_07-05-2021.pdf | 2021-05-07 |
| 8 | 202141006956-Proof of Right [19-05-2021(online)].pdf | 2021-05-19 |
| 9 | 202141006956-Correspondence_Form1_23-06-2021.pdf | 2021-06-23 |
| 10 | 202141006956-OTHERS [06-02-2023(online)].pdf | 2023-02-06 |
| 11 | 202141006956-FORM 18 [06-02-2023(online)].pdf | 2023-02-06 |
| 12 | 202141006956-EDUCATIONAL INSTITUTION(S) [06-02-2023(online)].pdf | 2023-02-06 |
| 13 | 202141006956-FER.pdf | 2023-02-28 |
| 14 | 202141006956-FORM 4(ii) [22-08-2023(online)].pdf | 2023-08-22 |
| 15 | 202141006956-POA [06-10-2023(online)].pdf | 2023-10-06 |
| 16 | 202141006956-MARKED COPIES OF AMENDEMENTS [06-10-2023(online)].pdf | 2023-10-06 |
| 17 | 202141006956-FORM 13 [06-10-2023(online)].pdf | 2023-10-06 |
| 18 | 202141006956-AMMENDED DOCUMENTS [06-10-2023(online)].pdf | 2023-10-06 |
| 19 | 202141006956-MARKED COPIES OF AMENDEMENTS [24-11-2023(online)].pdf | 2023-11-24 |
| 20 | 202141006956-FORM 13 [24-11-2023(online)].pdf | 2023-11-24 |
| 21 | 202141006956-FER_SER_REPLY [24-11-2023(online)].pdf | 2023-11-24 |
| 22 | 202141006956-COMPLETE SPECIFICATION [24-11-2023(online)].pdf | 2023-11-24 |
| 23 | 202141006956-CLAIMS [24-11-2023(online)].pdf | 2023-11-24 |
| 24 | 202141006956-AMMENDED DOCUMENTS [24-11-2023(online)].pdf | 2023-11-24 |
| 25 | 202141006956-FORM-8 [02-01-2024(online)].pdf | 2024-01-02 |
| 26 | 202141006956-US(14)-HearingNotice-(HearingDate-18-03-2024).pdf | 2024-02-28 |
| 27 | 202141006956-US(14)-HearingNotice-(HearingDate-07-06-2024).pdf | 2024-05-21 |
| 28 | 202141006956-Correspondence to notify the Controller [06-06-2024(online)].pdf | 2024-06-06 |
| 29 | 202141006956-Written submissions and relevant documents [13-06-2024(online)].pdf | 2024-06-13 |
| 30 | 202141006956-PatentCertificate30-07-2024.pdf | 2024-07-30 |
| 31 | 202141006956-IntimationOfGrant30-07-2024.pdf | 2024-07-30 |
| 1 | 202141006956E_15-02-2023.pdf |
| 2 | 1AE_29-11-2023.pdf |